Fred Hutchinson Cancer Center
Seattle, Washington, United States
Purpose
to carry out experimental studies in humans to determine if and how novel adjuvant and HIV-1 envelope immunogen combinations can induce higher levels, longer lasting, and qualitatively improved HIV-1 antibodies that may protect against HIV-
Division
Global Health
Date
November 2014
Region Served
GLOBAL
Committed amount
$4,740,863
Grant topic
HIV
Duration (months)
101
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.